http://dspace.bsu.edu.ru/handle/123456789/56826| Title: | Impact of COVID-19 on clinical trials protocol amendments |
| Authors: | Eleskina, A. A. Pyatigorskaya, N. V. Filippova, O. V. |
| Keywords: | medicine pharmacology COVID-19 clinical trials pandemic 2020 protocol amendments |
| Issue Date: | 2023 |
| Citation: | Eleskina, A.A. Impact of COVID-19 on clinical trials protocol amendments / A.A. Eleskina, N.V. Pyatigorskaya, O.V. Filippova // Research Results in Pharmacology. - 2023. - Vol.9, №2.-P. 11-15. |
| Abstract: | The COVID-19 pandemic situation had a great impact on all spheres of people’s lives. It also affected clinical trials as Sponsors, sites and investigators faced a number of problems, such as systematic IMP taking, adherence to protocol visits, efficacy evaluations, laboratory procedures, and analyses |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/56826 |
| Appears in Collections: | Vol. 9, № 2 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Eleskina_Impact_23.pdf | 223.02 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.